Abstract
Metformin-associated lactic acidosis (MALA) is a rare and potentially life-threatening complication of metformin use. It typically occurs in patients who are diabetic and also have other risk factors for lactic acidosis, including kidney and liver conditions, malignancy, or use of certain medications. We report a case of MALA in a man in his 70s with diabetes who presented with gradually worsening gastrointestinal symptoms, including severe abdominal pain and nausea. He reported these symptoms in the setting of metformin use with an acute kidney injury (AKI), likely brought on by poor oral intake and excessive antibiotic use for a urinary tract infection. He was promptly started on intravenous fluids with a bicarbonate drip to concurrently treat his prerenal AKI and lactic acidosis, which resulted in rapid resolution of his symptoms. Renal function normalised within 12 days of admission. Since diabetic patients commonly use metformin and are also at higher risk of renal dysfunction, this case highlights the vulnerability of this group of patients and the need for increased knowledge and awareness of MALA.
Reference14 articles.
1. The Current and Potential Therapeutic Use of Metformin-The Good Old Drug;Drzewoski;Pharmaceuticals (Basel),2021
2. Metformin-associated lactic acidosis: Current perspectives on causes and risk;DeFronzo;Metab Clin Exp,2016
3. Metformin-associated lactic acidosis: predisposing factors and outcome;Kim;Endocrinol Metab (Seoul),2015
4. Dyatlova N , Tobarran NV , Kannan L , et al . Metformin-associated lactic acidosis (mala). In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023.
5. Foucher CD , Tubben RE . Lactic acidosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023.